Growing incidences of thyroid gland imbalance, diabetes and arthritis is expected to drive growth of global market for carpal tunnel release. Increasing base of obesity and geriatric population is also contributing towards growth of the global market. Moreover, visual technological advancements in endoscopic surgery is likely to increase consumer base. Factors such as minimal reimbursement policies and high cost of surgeries will pose challenges for the global market.
Companies namely SONEX HEALTH, LLC. , Smith & Nephew, LMT Surgical, Integra LifeSciences Corporation, S.E.G-WAY Orthopaedics inc., A.M. SURGICAL, INC., Arthrex, Inc., Thayer Intellectual Property, Inc. and MicroAire Surgical Instruments, LLC among others will observe a major growth globally. Leading companies are working on marketing strategies such as developing advanced surgeries and expanding their product portfolio.
Sonex Health Partners With Samsung NeuroLogica for Developing Innovative Surgical Procedures
Sonex Health entered into a partnership with Samsung NeuroLogica for delivering innovative and disruptive treatment solutions, which can lead to better outcomes along with improved effectiveness. Both the companies will be promoting the significance of utilizing supreme quality ultrasound imaging in micro-invasive processes for optimizing outcomes and enhancing patient experience by increasing practice effectiveness. The elegant techniques of Sonex Health coupled with exquisite image quality of Samsung NeuroLogica will help in reducing surgical trauma.
SX-One MicroKnife® is the new technology that would enable micro-invasive CTR (carpal tunnel release) through a micro-incision. This surgery is five times smaller compared to incision made while standard CTR surgeries. Moreover, this incision can be closed just with the help of an adhesive strip or bandage. Musculoskeletal ultrasound imaging of high-quality is the major component for this process. Ultrasound guidance enables immediate visualization of the surrounding serious anatomy, with respect to device, during this process. It helps in protecting the patient’s anatomy and promotes rapid recovery. Patients can be benefitted with overall cost reduction in the surgery.
Sonex Health Receives Financing from the Economic Development Fund of Rochester
Sonex Health received financing of nearly $150,000 from the economic development fund of Rochester. It was the second investment made by the city leaders of RAEDI (Rochester Area Economic Development Inc.) to Sonex Health. The company is pulling in immense efforts to commercialize SX-One MicroKnife®, which is considered as a surgical device that holds “ultra-low profile”. This device helps the surgeons to perform the surgery of carpal tunnel release with one micro-incision, utilizing ultrasound guidance.
Sonex Health so far raised nearly $3.3Mn, which has been utilized in producing the final version of SX-One MicroKnife® and to acquire marketing clearance from FDA of the U.S. Until now, the company has sold nearly 350 units under the tagline of “limited release” model. These limited release models were specified to a selective group of doctors, who have been trained well and are currently using this device.
Sonex Health has developed significant progress from a model to a commercial invention and has acquired all relevant government clearances for the sale of its new technology as well. The major market players are focusing on developing analytical queries with the help of innovative carpal tunnel release surgeries and adopting several other approaches to improve their position in the global market.
A sample of this report is available upon request @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5965
